Lulifast XL 1% Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for effective penetration into the stratum corneum, ensuring targeted action at the site of infection. Lulifast XL 1% Cream is typically applied once daily to the affected area and surrounding skin for a duration recommended by a healthcare professional, usually ranging from one to two weeks depending on the infection type and severity. It is well tolerated with a low incidence of local adverse reactions such as mild burning, itching, or erythema. The product is contraindicated in patients with known hypersensitivity to luliconazole or any excipients in the formulation. As with all topical antifungals, patients should avoid contact with eyes and mucous membranes and adhere strictly to the prescribed treatment duration to prevent recurrence or resistance. Lulifast XL 1% Cream offers an effective and convenient option for managing common superficial fungal infections.